40 unchanged sentences
are filed as part of this document under Item 8 hereof:
−Removed: Report of Independent Registered Public Accounting Firm
+Added: Report of Independent Registered Public Accounting Firm (PCAOB ID:
Consolidated balance sheets at December 31, 2021 and 2020
1 unchanged sentence
Consolidated statements of comprehensive loss, years ended December 31, 2021, 2020 and 2019
−Removed: Consolidated statements of stockholders' equity (deficit), years ended December 31, 2020, 2019 and 2018
+Added: Consolidated statements of stockholders' equity, years ended December 31, 2021, 2020 and 2019
Consolidated statements of cash flows, years ended December 31, 2021, 2020 and 2019
3 unchanged sentences
Ref Description of Exhibits:
−Removed: Equity Interest Purchase Agreement, dated June 4, 2019, by and among OrthoPediatrics Corp., the Sellers and the Selling Equityholders (each as defined therein), and Abraham Lavi (as the Sellers’ representative).
−Removed: (Incorporated by reference to Exhibit 2.1 of registrant's Form 8-K filed on June 4, 2019) (SEC File No.
−Removed: Asset Purchase Agreement, dated December 31, 2019, by and among OrthoPediatrics Corp., Vilex in Tennessee, Inc., Orthex, LLC, Squadron Capital LLC and Squa Asset Purchase Agreement, dated December 31, 2019, by and among OrthoPediatrics Corp., Vilex in Tennessee, Inc., Orthex, LLC, Squadron Capital LLC and Squadron Newco LLC.
−Removed: (Incorporated by reference to Exhibit 2.1 of registrant's Form 8-K filed on January 6, 2020) (SEC File No.
Share Purchase Agreement, dated April 1, 2020, by and among OrthoPediatrics Corp., ApiFix Ltd.
11 unchanged sentences
registered pursuant to Section 12 of the Exchange Act
−Removed: Form of Director and Executive Office Indemnification and Advancement Agreement (Incorporated by reference to Exhibit 10.1 of registrant's Amendment No.
+Added: Form of Director and Executive Officer Indemnification and Advancement Agreement (Incorporated by reference to Exhibit 10.1 of registrant's Amendment No.
3 to Form S-1 filed on October 2, 2017) (SEC File No.
5 unchanged sentences
* OrthoPediatrics Corp.
−Removed: Non-Employee Director Compensation Policy (Incorporated by reference to Exhibit 10.4 of registrant's Amendment No.
−Removed: 3 to Form S-1 filed on October 2, 2017) (SEC File No.
−Removed: * Employment Agreement, by and between the registrant and Mark C.
−Removed: Throdahl, dated as of July 31, 2014 (Incorporated by reference to Exhibit 10.5 of registrant's Form S-1 filed on June 16, 2016) (SEC File No.
+Added: Non-Employee Director Compensation Policy, effective January 1, 2022 (Incorporated by reference to Exhibit 10.1 of registrant's Form 8-K filed on November 4, 2021) (SEC File No.
* Employment Agreement, by and between the registrant and Fred L.
13 unchanged sentences
and each of its subsidiaries party thereto (Incorporated by reference to Exhibit 10.4 of registrant's Form 10-Q filed on August 6, 2020) (SEC File No.
+Added: Third Amendment to the Fourth Amended and Restated Loan Agreement, date as of December 31, 2021, by and among OrthoPediatrics Corp., its subsidiaries named therein and Squadron Capital LLC (Incorporated by reference to Exhibit 10.1 of registrant's Form 8-K filed on January 6, 2022) (SEC File No.
+ Subsidiaries of the registrant
18 unchanged sentences
FORM 10-K SUMMARY
−Removed: Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 11th day of March, 2021.
+Added: Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 3rd day of March, 2022.
OrthoPediatrics Corp.
−Removed: Chief Executive Officer
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, this report on Form 10-K has been signed by the following persons on behalf of the registrant and in the capacities indicated, on this 11th day of March, 2021.
−Removed: Throdahl /s/ Fred L.
−Removed: Chief Executive Officer
+Added: President and Chief Executive Officer
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, this report on Form 10-K has been signed by the following persons on behalf of the registrant and in the capacities indicated, on this 3rd day of March, 2022.
+Added: Bailey /s/ Fred L.
+Added: Director, President and Chief Executive Officer
(Principal Executive Officer)
−Removed: Chief Financial Officer and Chief Operating Officer
+Added: Director, Chief Financial Officer and Chief Operating Officer
(Principal Financial and Accounting Officer)
−Removed: Bailey /s/ Bernie B.
−Removed: President Bernie B.
−Removed: Schlotterback * /s/ Bryan W.
Schlotterback
−Removed: /s/ Stephen F.
−Removed: Burns * /s/ David R.
−Removed: Infante * /s/ Kevin L.
−Removed: /s/ Harold Ruf * /s/ Samuel D.
* By Daniel J.
−Removed: Gerritzen as Attorney-in Fact pursuant to a Limited Power of Attorney executed by the directors listed above, which Power of Attorney is being filed with the Securities and Exchange Commission as an exhibit hereto.
+Added: Gerritzen as Attorney-in Fact pursuant to a Limited Power of Attorney executed by the directors identified above, which Power of Attorney is being filed with the Securities and Exchange Commission as an exhibit hereto.
/s/ Daniel J.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.